Company Information

VAISHALI PHARMA LTD.

NSE : VAISHALIBSE : ISIN CODE : INE972X01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( )0 0
NSE140.05-6.35 (-4.34 %)
PREV CLOSE( ) 146.40
OPEN PRICE ( ) 147.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 140.05 (2414)
VOLUME 113427
TODAY'S LOW / HIGH( ) 138.20 147.85
52 WK LOW / HIGH ( )114.85 203.6
ChairmanAtul Vasani
Managing DirectorAtul Vasani
Company SecretaryVishwa Mekhia
Executive DirectorDewansh Vasani
Non Executive Independent DirectorPratik Jakhelia
Ashvin Jamnadas Ganatra
Manish Bhagwandas Ved
Whole Time DirectorJagruti Vasani
Incorporation Year : 25-04 2008

Registered Office :

Address : 706 To 709, 7th Floor, Aravali Busines Center,R. C. Patel Road, Off Sodawala Lane,Borivali (West) Mumbai,
Maharashtra-400092 .

Phone : 022 42171819

Industry : Pharmaceuticals & Drugs

Listing : NSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.